Tag Archives: 35/2014

Clinical trial unit health research

Roland JonssonHealth research in register epidemiology and studies of the general population have yielded important public health information both nationally and locally. In recent years, various fields such as health research on nutrition and vaccine development have contributed to increased activity in clinical trials on humans. In addition, Norway has advantages which make possible unique population-based studies on various medicinal drugs. In order to enhance existing research, and to enable new research on humans, the University of Bergen and Helse Bergen wish to establish a trial unit, which satisfies the demands required for clinical studies of high quality.

The work group tasked with assessing this possibility was established at the faculty in June 2013. The group has now submitted a proposal. Using a pilot study and experiences from the Research Post for Adults (Helse Bergen) as a starting point, the group has worked out a report which outlines a clinical trial unit meant to provide service to increasing activities in health research in the years to come. It is the opinion of the work group that the collaboration between the university and the health institution in such a research unit will stimulate to more research of highest international quality in the years to come. Department of Clinical Science has been given responsibility for this unit, which follows the same guidelines as the faculty’s core facilities. If anyone wishes to register a project, please notify K2’s Head of Administration, Synnøve Myhre.


Public defence week 36

johannes_schrama_sv-hvJohannes Cornelis Schrama will have his public defence on Friday September 5, 2014.
Trial lecture: Thursday September 4, 2014, 13:15
Topic: «Septisk artritt»
Public defence: Friday September 5, 2014, 09:15
Place: Aud. 4, BB-building, Jonas Lies vei 91
Title of dissertation
: «Infected hip and knee arthroplasties in rheumatoid arthritis. A register-based study with focus on risk factors»
1st opponent: Ph.d. Finnur Snorrason, Drammen Hospital
2nd opponent:
Ph.d. Hanne Osnes Ringen, Diakonhjemmet Hospital, Oslo
Poster and press release(both in Norwegian)

PEK-funds 2015

Program for evaluation and quality development (PEK-funds) will give out 1,3 million NOK in 2015. The program is two-fold, consisting of a project part (>70%) and a reward part, the Owl Award for good study quality (<30%). The Projects will generally promote the quality of education and the quality of the student-oriented services at the University, and be transferable to other disciplines.
Deadline is September 10th 2014. For more information (in Norwegian).


We wish to invite you all to the next monthly K1/K2 Seminar Series!
Title: “The gut microbiota – the forgotten organ”


Held by Johannes Espolin Roksund Hov, Norwegian center for primary sclerosing cholangitis (NoPSC), Oslo University Hospital, Rikshospitalet.

When: Wednesday, September 3, 14:15-15:00.
Where: Main Auditorium, 3rd floor, Sentralblokken.
Chair: Elling Ulvestad


The administration at Department of Clinical Science will host an information meeting on Wednesday September 10, at 13:00-14:30. The meeting will take place in the seminar room on the 9th floor of the Laboratory Building. Practical information regarding HR, financial matters and general PhD-routines will be presented. The meeting is open for anyone interested in attending, but new PhD-Candidates and postdocs are in particular encouraged to attend.